Movement Alert|Humana Rises 5.25% in Regular Trading, Multiple Investment Banks Raise Target Prices Boosting Market Confidence

Market Focus06-04 22:23

On June 4, Humana rose 5.25% in regular trading, trading at $347.685/share, with trading volume of $128 million. The stock rallied as multiple investment banks issued upgraded price targets in quick succession.

Bernstein significantly raised its target price on Humana from $288 to $425, maintaining an Outperform rating. Truist lifted its target from $270 to $320 while maintaining a Hold rating, and Morgan Stanley raised its target from $217 to $249. Prior to the upgrades, Humana reaffirmed its full-year adjusted earnings guidance of at least $9 per share, ahead of the FactSet consensus estimate of $8.93, with senior management scheduled to meet investors throughout June.

The broader Managed Health Care sector rallied in tandem, with Centene up 6.18%, UnitedHealth up 5.72%, Molina Healthcare up 4.89%, Elevance Health up 4.34%, and Alignment Healthcare up 8.84%, reflecting broad sector strength that further supported Humana's advance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment